In myositis, myositis-specific and associated antibodies like anti-melanoma differentiation-associated protein 5 (anti-MDA-5) are an independent risk factor for rapid progressive ILD with high mortality, while anti-aminoacyl tRNA synthetase (anti-ARS) antibodies are associated with subacute ILD (97–99). Here, IFIH1 is linked to interstitial lung disease.